相关实验视频

Updated: May 2, 2026

Protocol for Microplastics Sampling on the Sea Surface and Sample Analysis

Protocol for Microplastics Sampling on the Sea Surface and Sample Analysis

Published on: December 16, 2016

了解微塑料暴露后对人类健康的影响需要标准化的协议

Sarah E Morgan¹, Samantha S Romanick², Lisa DeLouise³

¹Department of Environmental Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York, United States.

Current protocols

|July 17, 2024

概括

微塑料 (MP) 是一个日益严重的环境问题. 本研究回顾了评估MP生物活性的方法,强调了挑战,并提出了对人类健康影响的可靠研究的标准化.

科学领域:

环境科学环境科学
毒理学毒理学毒理学
生物技术是生物技术.

背景情况:

微塑料 (MPs) 是普遍存在的污染物,人类暴露的路径有记录.
了解MP暴露的生物影响是非常重要的,因为它们的持久性.
MP的影响取决于粒子特性,剂量和暴露途径.

研究的目的:

为目前评估微塑料生物活性的方法提供视角.
确定微塑料生物活性研究中的挑战.
为标准化微塑料研究提出解决方案.

主要方法:

在生物活性研究中使用的测定,暴露条件和参考MP颗粒的审查.
分析与仪器仪表,参考材料和剂量计相关的挑战.
讨论提议的解决方案,以提高研究适用性和减少冗余性.

主要成果:

目前采用了各种各样的检测方法和暴露条件.
由于仪器仪表,缺乏标准化材料和剂量计存在重大挑战.
提出的解决方案旨在提高研究的一致性和可比性.

结论:

方法的标准化对于推进微塑料生物活性研究至关重要.
应对当前的挑战将导致更可靠的知识基础.
未来的研究应该专注于可重复和标准化的协议.

关键词:

生物可用性生物可用性剂量测量方法剂量测量方法风险暴露风险暴露风险暴露微塑料微塑料的使用参考材料是参考材料的参考材料.

更多相关视频

Sampling, Sorting, and Characterizing Microplastics in Aquatic Environments with High Suspended Sediment Loads and Large Floating Debris

Sampling, Sorting, and Characterizing Microplastics in Aquatic Environments with High Suspended Sediment Loads and Large Floating Debris

Published on: July 28, 2018

Sampling, Identification and Characterization of Microplastics Release from Polypropylene Baby Feeding Bottle during Daily Use

Sampling, Identification and Characterization of Microplastics Release from Polypropylene Baby Feeding Bottle during Daily Use

Published on: July 24, 2021

相关概念视频

Toxicity Testing in Animals

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...